Metraipolis › archive › dc_f277516e38bd

Development of a PK/PD-Efficacy Modeling Framework for Covalent Inhibitors — Europe PMC PMID:42653726

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42653726
DOI
10.3390/ph19081228
License (as archived)
solo-consultazione
Archived
2026-10-17T04:27:09.620Z
SHA-256 of the archived text
86794b58d0eaa06f59bb591ea76251e3926ac322959d7544946c5638e153db26
Stable URL of this page
https://metraipolis.com/documento/dc_f277516e38bd

How to cite

Development of a PK/PD-Efficacy Modeling Framework for Covalent Inhibitors — Europe PMC PMID:42653726 — Europe PMC (en), https://europepmc.org/article/MED/42653726 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f277516e38bd (Metraipolis archive dc_f277516e38bd, sha256 86794b58d0eaa06f59bb591ea76251e3926ac322959d7544946c5638e153db26)
BibTeX
@misc{dcf277516e38bd,
  title = {Development of a PK/PD-Efficacy Modeling Framework for Covalent Inhibitors — Europe PMC PMID:42653726},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42653726},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f277516e38bd; sha256 86794b58d0eaa06f59bb591ea76251e3926ac322959d7544946c5638e153db26},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42653726. Agents can read the archived copy with the MCP tool read_document.